Key result
Cilostazol prevented no-reflow and hemorrhagic transformation in mice with focal cerebral ischemia by maintaining microvascular integrity.
Why the study?
Does cilostazol prevent no-reflow and hemorrhage in mice with focal cerebral ischemia?
Does cilostazol prevent no-reflow and hemorrhage in mice with focal cerebral ischemia?
In a murine model of focal cerebral ischemia, cilostazol demonstrated protective effects by maintaining microvascular integrity and preventing no-reflow and hemorrhagic transformation.
Does not support cilostazol use in human stroke; leaves open translation from murine microvascular protection.
Cilostazol may possess protective properties against cerebral ischemic injury by preventing no-reflow and hemorrhagic transformation, via maintenance of microvascular integrity.
No takes yet. Share an insight, caveat, or question.
Hase et al. (2011) studied this question. Cilostazol prevented no-reflow and hemorrhagic transformation in mice with focal cerebral ischemia by maintaining microvascular integrity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: